digplanet beta 1: Athena
Share digplanet:

Agriculture

Applied sciences

Arts

Belief

Business

Chronology

Culture

Education

Environment

Geography

Health

History

Humanities

Language

Law

Life

Mathematics

Nature

People

Politics

Science

Society

Technology

Esreboxetine
Systematic (IUPAC) name
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine
Clinical data
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral
Identifiers
CAS number 98819-76-2
ATC code None
UNII L8S50ZY490 YesY
KEGG D09340 YesY
Chemical data
Formula C19H23NO3 
Mol. mass 313.391 g/mol
 YesY (what is this?)  (verify)

Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued.[1][2][3][4] It is the (+)-(S,S)-enantiomer of reboxetine and is even more selective in comparison.[1][5]

However, recently it has been shown that esreboxetine could be effective in fibromyalgia patients.[6]

See also [edit]

References [edit]

  1. ^ a b Matilda Bingham; Napier, Susan Jolliffe (2009). Transporters as Targets for Drugs (Topics in Medicinal Chemistry). Berlin: Springer. ISBN 3-540-87911-0. 
  2. ^ Rao SG (October 2009). "Current progress in the pharmacological therapy of fibromyalgia". Expert Opinion on Investigational Drugs 18 (10): 1479–93. doi:10.1517/13543780903203771. PMID 19732029. 
  3. ^ "Search of: esreboxetine - List Results - ClinicalTrials.gov". 
  4. ^ "Musculoskeletal Report: Pfizer Stops Work on Esreboxetine for FM". 
  5. ^ Fish, P. V.; MacKenny, M.; Bish, G.; Buxton, T.; Cave, R.; Drouard, D.; Hoople, D.; Jessiman, A. et al. (2009). "Enantioselective synthesis of (R)- and (S)-N-Boc-morpholine-2-carboxylic acids by enzyme-catalyzed kinetic resolution: application to the synthesis of reboxetine analogs". Tetrahedron Letters 50 (4): 389. doi:10.1016/j.tetlet.2008.11.025.  edit
  6. ^ Arnold, L. M., Hirsch, I., Sanders, P., Ellis, A. and Hughes, B. (2012), Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis & Rheumatism, 64: 2387–2397. doi: 10.1002/art.34390




Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/Esreboxetine — Please support Wikipedia.
A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.

Youtube says it doesn't have anything for Esreboxetine.

We're sorry, but there's no news about "Esreboxetine" right now.

Loading

Oops, we seem to be having trouble contacting Twitter

Talk About Esreboxetine

You can talk about Esreboxetine with people all over the world in our discussions.

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!